Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,083) with videos related to
Page
of 109
Sort By:
Journal of Medicinal Chemistry
|
April 4, 2020
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis
Thomas J Struble, Juan C Alvarez, Scott P Brown, et al.
Nature Communications
|
May 16, 2025
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca<sup>2+</sup> dependent allosteric binding site
Leslie A Dakin, Li Xing, Justin Hall, et al.
Scientific Reports
|
August 17, 2016
Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists
Shenping Liu, Leslie A Dakin, Li Xing, et al.
Journal of Nanobiotechnology
|
July 6, 2022
A universal strategy for the fabrication of single-photon and multiphoton NIR nanoparticles by loading organic dyes into water-soluble polymer nanosponges
Li-Xing Yang, Yu-Cheng Liu, Chang-Hui Cho, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase
Shaun R Selness, Terri L Boehm, John K Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase
Shaun R Selness, Rajesh V Devraj, Balekudru Devadas, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning
Mark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Journal of Medicinal Chemistry
|
August 17, 2018
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Hepatology International
|
December 28, 2020
A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC
Xia Sheng, Yuan Ji, Guo-Ping Ren, et al.
Nature Genetics
|
October 15, 2013
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
Guangwu Guo, Xiaojuan Sun, Chao Chen, et al.
Page
of 109
Search research articles
Search
Showing results (1071-1080 of 1,083) with videos related to
Sort By:
Page
of 109
Journal of Medicinal Chemistry
|
April 4, 2020
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis
Thomas J Struble, Juan C Alvarez, Scott P Brown, et al.
Nature Communications
|
May 16, 2025
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca<sup>2+</sup> dependent allosteric binding site
Leslie A Dakin, Li Xing, Justin Hall, et al.
Scientific Reports
|
August 17, 2016
Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists
Shenping Liu, Leslie A Dakin, Li Xing, et al.
Journal of Nanobiotechnology
|
July 6, 2022
A universal strategy for the fabrication of single-photon and multiphoton NIR nanoparticles by loading organic dyes into water-soluble polymer nanosponges
Li-Xing Yang, Yu-Cheng Liu, Chang-Hui Cho, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase
Shaun R Selness, Terri L Boehm, John K Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase
Shaun R Selness, Rajesh V Devraj, Balekudru Devadas, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning
Mark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Journal of Medicinal Chemistry
|
August 17, 2018
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Hepatology International
|
December 28, 2020
A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC
Xia Sheng, Yuan Ji, Guo-Ping Ren, et al.
Nature Genetics
|
October 15, 2013
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
Guangwu Guo, Xiaojuan Sun, Chao Chen, et al.
Page
of 109